- By insider
CEO of Array Biopharma Inc (ARRY) Ron Squarer sold 819,671 shares of ARRY on 12/19/2017 at an average price of $10.86 a share. The total sale was $8.9 million.
Array BioPharma Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Array BioPharma Inc has a market cap of $2.14 billion; its shares were traded at around $10.87 with and P/S ratio of 13.09.
-
Warning! GuruFocus has detected 2 Warning Sign with ARRY. Click here to check it out.
-
The intrinsic value of ARRY
CEO Recent Trades:
-
CEO Ron Squarer sold 819,671 shares of ARRY stock on 12/19/2017 at the average price of $10.86. The price of the stock has increased by 0.09% since.
Directors and Officers Recent Trades:
-
COO Andrew R Robbins sold 282,874 shares of ARRY stock on 12/18/2017 at the average price of $10.72. The price of the stock has increased by 1.4% since.
For the complete insider trading history of ARRY, click here
.This article first appeared on GuruFocus.
-
Warning! GuruFocus has detected 2 Warning Sign with ARRY. Click here to check it out.
-
The intrinsic value of ARRY